Facebook Linkedin RSS Twitter Youtube
Home 2023

Influenza virus

Eliminating Blind Spots in Pandemic Preparedness
Infectious Diseases

Eliminating Blind Spots in Pandemic Preparedness

What’s Next for mRNA Vaccines?
Cancer

What’s Next for mRNA Vaccines?

Z-DNA Triggering Drug Kills Immunotherapy Resistant Melanoma by Mimicking Flu
Cancer

Z-DNA Triggering Drug Kills Immunotherapy Resistant Melanoma by Mimicking Flu

Human Lung Chip Speeds Drug Discovery for COVID-19 and Flu
Coronavirus

Human Lung Chip Speeds Drug Discovery for COVID-19 and Flu

Next-Generation Sequencing Boosts Clinical Metagenomics
Infectious Diseases

Next-Generation Sequencing Boosts Clinical Metagenomics

Exposure to H1N1 Flu Recalls Neutralizing Antibodies, Bolsters Universal Vaccine Strategy
Drug Discovery

Exposure to H1N1 Flu Recalls Neutralizing Antibodies, Bolsters Universal Vaccine Strategy

Small, Recurrent Deletions in SARS-CoV-2’s Spike Protein May Drive Antibody Escape
Coronavirus

Small, Recurrent Deletions in SARS-CoV-2’s Spike Protein May Drive Antibody Escape

Custom Service for Influenza Antigens
New Products

Custom Service for Influenza Antigens

Severe COVID-19 Cases Linked to Genes, Autoimmunity, and Interferon Disruption
Coronavirus

Severe COVID-19 Cases Linked to Genes, Autoimmunity, and Interferon Disruption

T-Cell-Based Vaccine Effective against Multiple Influenza Virus Strains
Coronavirus

T-Cell-Based Vaccine Effective against Multiple Influenza Virus Strains

123...12Page 2 of 12
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.